Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Let’s be clear, after the recent £31 million fund raise, with no imminent cash crisis, Avacta (AVCT) is no longer a compelling short at 53p. We perma bears have won, drunk our ouzo and moved on, to the sound of gnashing teeth among impoverished bulletin board poltroons. But when it next starts to run out of cash its shares will collapse. And its valuation, £187 million plus another £40 million when all death spirals are converted looks very chunky indeed for a company whose lead product is not yet in phase 2 trials. Today there is more “news” but it means nothing at all and strikes me as a desperate attempt to keep the shares above the 50p placing price.
Already a member? Sign in
• All premium articles
• Tom Winnifrith’s Bearcast
• Access to all the entire nearly 13 year archive
• ShareProphets Daily Newsletter
Cancel any time
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.